4.7 Article

Food allergy: A practice parameter update-2014

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 134, Issue 5, Pages 1016-+

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2014.05.013

Keywords

Food allergy; food allergen; cross-reactivity; adverse food reactions; IgE-mediated food allergy; eosinophilic esophagitis

Funding

  1. National Institute of Allergy and Infectious Disease (NIAID) [AI44236, AI66738]
  2. National Institutes of Health (NIH) [RR026134]
  3. Food Allergy Research and Education (FARE)
  4. NIH (NIAID) [AI092135]
  5. Department of Defense
  6. American Academy of Allergy, Asthma & Immunology (AAAAI)/American Partnership for Eosinophilic Disorders
  7. NIH (COFAR)
  8. NIH/NIAID Immune Tolerance Network [A1-15416]
  9. Data Safety Monitoring Board for Merck [0955]
  10. Nutricia
  11. NIH
  12. AstraZeneca
  13. GlaxoSmithKline
  14. Merck
  15. Boehringer Ingelheim
  16. Novartis
  17. MedImmune

Ask authors/readers for more resources

This parameter was developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma & Immunology (JCAAI). The AAAAI and the ACAAI have jointly accepted responsibility for establishing Food Allergy: A practice parameter update-2014. This is a complete and comprehensive document at the current time. The medical environment is a changing one, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, ACAAI, and JCAAI. These parameters are not designed for use by pharmaceutical companies in drug promotion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available